BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28039706)

  • 1. Partial versus radical nephrectomy for pT1a renal cancer in Serbia.
    Janicic A; Bumbasirevic U; Pekomezovic T; Cekerevac M; Acimovic M; Dzamic Z; Tulic C
    J BUON; 2016; 21(6):1449-1453. PubMed ID: 28039706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
    Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
    Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score.
    Kopp RP; Mehrazin R; Palazzi KL; Liss MA; Jabaji R; Mirheydar HS; Lee HJ; Patel N; Elkhoury F; Patterson AL; Derweesh IH
    BJU Int; 2014 Nov; 114(5):708-18. PubMed ID: 24274650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors.
    Mano R; Kent M; Larish Y; Winer AG; Chevinsky MS; Hakimi AA; Sternberg IA; Sjoberg DD; Russo P
    Urology; 2015 Jun; 85(6):1404-10. PubMed ID: 25872696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
    Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
    Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
    Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
    Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
    Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
    Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
    Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.
    Forbes CM; Rendon RA; Finelli A; Kapoor A; Moore RB; Breau RH; Lacombe L; Kawakami J; Drachenberg DE; Pautler SE; Jewett MMA; Saarela O; Liu Z; Tanguay S; Black PC
    Urol Oncol; 2016 Nov; 34(11):486.e17-486.e23. PubMed ID: 27423824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
    Takagi T; Kondo T; Iizuka J; Omae K; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    BJU Int; 2016 Jun; 117(6B):E52-9. PubMed ID: 26073989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial nephrectomy versus radical nephrectomy for large (≥ 7 cm) renal tumors: A systematic review and meta-analysis.
    Deng W; Chen L; Wang Y; Liu X; Wang G; Fu B
    Urol Oncol; 2019 Apr; 37(4):263-272. PubMed ID: 30704957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.